jvl associates llc bought a brand new place in shares of AbbVie Inc. (NYSE:ABBV – Free Report) throughout the third quarter, Holdings Channel.com stories. The fund bought 1,101 shares of the corporate’s inventory, valued at roughly $217,000.
A number of different hedge funds have additionally made modifications to their positions within the inventory. West Coast Monetary LLC grew its holdings in AbbVie by 9.7% within the 1st quarter. West Coast Monetary LLC now owns 1,578 shares of the corporate’s inventory price $287,000 after shopping for a further 140 shares within the final quarter. FCG Funding Co purchased a brand new place in AbbVie throughout the 1st quarter valued at $1,413,000. Safeguard Monetary LLC purchased a brand new stake in AbbVie within the first quarter price about $235,000. BluePath Capital Administration LLC raised its holdings in shares of AbbVie by 0.9% within the 1st quarter. BluePath Capital Administration LLC now owns 7,311 shares of the corporate’s inventory price $1,331,000 after buying a further 67 shares within the final quarter. Lastly, Voisard Asset Administration Group Inc. acquired a brand new stake in AbbVie throughout the fourth quarter valued at roughly $87,000. Institutional buyers personal 70.23% of the corporate’s inventory.
Insider Shopping for and Promoting at AbbVie
In different information, Chairman Richard A. Gonzalez bought 66,500 shares of the corporate’s inventory in a transaction dated Monday, August fifth. The inventory was bought at a mean value of $186.52, for a complete transaction of $12,403,580.00. Following the completion of the sale, the chairman now owns 446,599 shares within the firm, valued at roughly $83,299,645.48. This represents a 0.00 % lower of their place. The transaction was disclosed in a authorized submitting with the SEC, which may be accessed by means of this hyperlink. In associated information, Chairman Richard A. Gonzalez bought 282,845 shares of the enterprise’s inventory in a transaction dated Wednesday, July seventeenth. The inventory was bought at a mean value of $175.00, for a complete transaction of $49,497,875.00. Following the completion of the transaction, the chairman now owns 513,099 shares of the corporate’s inventory, valued at roughly $89,792,325. The commerce was a 0.00 % lower of their place. The transaction was disclosed in a doc filed with the Securities & Trade Fee, which is accessible by means of this hyperlink. Additionally, Chairman Richard A. Gonzalez bought 66,500 shares of the inventory in a transaction that occurred on Monday, August fifth. The shares had been bought at a mean value of $186.52, for a complete worth of $12,403,580.00. Following the sale, the chairman now owns 446,599 shares of the corporate’s inventory, valued at roughly $83,299,645.48. The commerce was a 0.00 % lower of their place. The disclosure for this sale may be discovered right here. Company insiders personal 0.25% of the corporate’s inventory.
AbbVie Inventory Down 0.6 %
ABBV traded down $1.16 throughout buying and selling on Friday, reaching $194.29. 4,749,637 shares of the inventory traded fingers, in comparison with its common quantity of 5,336,546. AbbVie Inc. has a fifty-two week low of $135.85 and a fifty-two week excessive of $199.95. The inventory’s 50-day easy transferring common is $193.17 and its two-hundred day easy transferring common is $176.74. The corporate has a debt-to-equity ratio of 8.51, a present ratio of 0.81 and a fast ratio of 0.71. The inventory has a market cap of $343.09 billion, a price-to-earnings ratio of 57.56, a price-to-earnings-growth ratio of two.65 and a beta of 0.64.
AbbVie (NYSE:ABBV – Get Free Report) final launched its quarterly earnings knowledge on Thursday, July twenty fifth. The corporate reported $2.65 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.08. The agency had income of $14.46 billion for the quarter, in comparison with the consensus estimate of $14.02 billion. AbbVie had a return on fairness of 203.66% and a web margin of 9.71%. The agency’s income was up 4.3% on a year-over-year foundation. Throughout the identical quarter within the prior yr, the corporate posted $2.91 earnings per share. As a bunch, equities analysis analysts anticipate that AbbVie Inc. will submit 10.86 EPS for the present yr.
AbbVie Publicizes Dividend
The agency additionally just lately introduced a quarterly dividend, which might be paid on Friday, November fifteenth. Shareholders of file on Tuesday, October fifteenth might be given a dividend of $1.55 per share. This represents a $6.20 annualized dividend and a yield of three.19%. The ex-dividend date is Tuesday, October fifteenth. AbbVie’s payout ratio is 183.98%.
Wall Road Analysts Forecast Development
Various brokerages just lately issued stories on ABBV. BMO Capital Markets lifted their goal value on AbbVie from $180.00 to $214.00 and gave the inventory an “outperform” ranking in a report on Friday, July nineteenth. Wells Fargo & Firm boosted their value goal on AbbVie from $200.00 to $205.00 and gave the inventory an “obese” ranking in a report on Friday, July twenty sixth. Morgan Stanley raised their goal value on shares of AbbVie from $211.00 to $218.00 and gave the inventory an “obese” ranking in a report on Monday, August twelfth. Cantor Fitzgerald restated an “obese” ranking and set a $200.00 value goal on shares of AbbVie in a report on Monday, August fifth. Lastly, Piper Sandler raised their value goal on shares of AbbVie from $196.00 to $209.00 and gave the inventory an “obese” ranking in a analysis be aware on Friday, August twenty third. Two funding analysts have rated the inventory with a maintain ranking, twelve have issued a purchase ranking and two have given a robust purchase ranking to the corporate. In response to knowledge from MarketBeat, the corporate has a consensus ranking of “Purchase” and a consensus value goal of $191.64.
Learn Our Newest Inventory Report on AbbVie
AbbVie Profile
AbbVie Inc discovers, develops, manufactures, and sells prescription drugs worldwide. The corporate provides Humira, an injection for autoimmune and intestinal Behçet’s ailments, and pyoderma gangrenosum; Skyrizi to deal with reasonable to extreme plaque psoriasis, psoriatic illness, and Crohn’s illness; Rinvoq to deal with rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn’s illness; Imbruvica for the remedy of grownup sufferers with blood cancers; Epkinly to deal with lymphoma; Elahere to deal with most cancers; and Venclexta/Venclyxto to deal with blood cancers.
See Additionally
Wish to see what different hedge funds are holding ABBV? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for AbbVie Inc. (NYSE:ABBV – Free Report).
Obtain Information & Rankings for AbbVie Day by day – Enter your e mail deal with under to obtain a concise each day abstract of the newest information and analysts’ scores for AbbVie and associated corporations with MarketBeat.com’s FREE each day e mail e-newsletter.
